Genotypic portrait of SARS-COV-2 in the Republic of Belarus in 2020–2021
https://doi.org/10.58708/2074-2088.2026-1(37)-54-60
Abstract
Based on partial sequencing data of the S gene from 2 066 clinical samples, the spectrum of SARS-CoV-2 variants was determined and the characteristics of their spread in the Republic of Belarus in 2020–2021 were established. At the beginning of 2020, predominantly early «Wuhan» variants were identified: A.1 in Minsk and B.1 in the Vitebsk Region. In the 2nd–3rd quarters, all analyzed sequences belonged to variant B.1, which remained the leader in the 4th quarter (90,6%). Rare B.1 sublineages collectively accounted for 9,4%, among which variant B.1.1.374 predominated. Regional differences during this period were not significant (p>0,05). The Alpha variant displaced the early variants (including B.1.1.374) in the first quarter of 2021, becoming dominant. The Delta variant, represented predominantly by AY.4, began to active spread from May 2021 and by summer completely replaced Alpha. Regional differences in 2020–2021 were not significant (p>0,05).
About the Authors
K. Y. BuldaBelarus
E. L. Gasich
Belarus
A. D. Kosko
Belarus
References
1. W. T. Harvey, A. M. Carabelli, B. Jackson. SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology. 2021;19(7). DOI: 10.1038/s41579-021-00573-0
2. S. P. Otto, T. Day, J. Arino. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. 2021;31(14). DOI: 10.1016/j.cub.2021.06.049
3. J. A. Plante, Y. Liu, J. Liu. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592(7852). DOI: 10.1038/s41586-020-2895-3
4. A. Saito, T. Irie, R. Suzuki. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602(7896). DOI: 10.1038/s41586-021-04266-9
5. W. S. Chan, Y. M. Lam, J. H. Y. Law, Geographical prevalence of SARS-CoV-2 variants, August 2020 to July 2021, Scientific Reports. 2022;12(1). DOI: 10.1038/s41598-022-08684-1
6. M. Miklasińska-Majdanik, E. Morawiec, J. Bratosiewicz-Wąsik. From Delta to Omicron—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland. Pathogens. 2025;14(7). DOI: 10.3390/pathogens14070708
7. Bulda K. Y., Gasich E. L., Kosko A. D. Spread of genetic variants of the SARS-CoV-2 virus in Minsk in February–May 2021. Advances in medicine and medical sciences. 2023;13: 125-131. (In Russ.).
8. An imported case of coronavirus has been registered in Belarus. Press Service of the Ministry of Health, February 28, 2020. – URL: https://minzdrav.gov.by/ru/sobytiya/v-belarusi-zaregistrirovan-zavoznoy-sluchay-koronavirusa/ (date of access: December 30, 2025). (In Russ.)
9. E. Cella, F. Benedetti, S. Fabris. SARS-CoV-2 lineages and sub-lineages circulating worldwide: a dynamic overview. Chemotherapy. 2021;66(1–2). DOI. 10.1159/000515340
10. Akimkin V.G., Popova A.Y., Khafizov K.F. COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants. Journal of microbiology, epidemiology and immunobiology. 2022;99(4). DOI: 10.36233/0372-9311-295. (In Russ.)
11. L. Rabalski, M. Kosinski, N. Mazur-Panasiuk. Zoonotic spill-over of SARS-CoV-2: mink-adapted virus in humans. Clinical Microbiology and Infection. 2022;28(3). DOI: 10.1016/j.cmi.2021.12.001
12. B. Brejová, K. Boršová, V. Hodorová. A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020. Virus Genes. 2021;57(6). DOI: 10.1007/s11262-021-01866-5
13. E. Morawiec, M. Miklasińska-Majdanik, J. Bratosiewicz-Wąsik. From Alpha to Delta-genetic epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland. Pathogens. 2022;11(7). DOI: 10.3390/pathogens11070780
14. T. Funk, A. Pharris, G. Spiteri. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Eurosurveillance. 2021;26(16). DOI: 10.2807/1560-7917.ES.2021.26.16.2100348
15. R. El-Shesheny, A. El Taweel, M. R. Gomaa. Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak. Vaccine. 2022;40(32). DOI: 10.1016/j.vaccine.2022.05.086
Review
For citations:
Bulda K.Y., Gasich E.L., Kosko A.D. Genotypic portrait of SARS-COV-2 in the Republic of Belarus in 2020–2021. Medical and Biological Problems of Life Activity. 2026;(1):54-60. (In Russ.) https://doi.org/10.58708/2074-2088.2026-1(37)-54-60
JATS XML







